Israeli-U.S. Startup OncoHost Honored for Groundbreaking Cancer Research

Jerusalem, 10 July, 2025 (TPS-IL) — OncoHost, a precision medicine technology company based in Israel and the U.S., was named a Gold Winner in the 2025 Merit Awards for Business in the Research and Development category. The award recognizes OncoHost’s innovative PROphet platform, an AI-driven proteomics solution that guides immunotherapy decisions for cancer patients.

CEO Dr. Ofer Sharon called the honor a validation of their bold scientific work, emphasizing their mission to help oncologists tailor treatments for better patient outcomes. OncoHost’s AI-powered liquid biopsy tests are advancing personalized cancer care, with products targeting lung, kidney, and melanoma cancers currently in development.